The association of chronic lymphocytic leukemia (CLL) and acute leukemia (AL) is rare. [1] .
In most cases, AL develops after treatment of CLL, thus, previous chemotherapy or radiotherapy is usually considered as a leukemogenic event [2] .
We report two cases of acute leukemia occurring in patients with untreated chronic lymphocytic leukemia with remarkably similar time cluster. Those two ALs had the same morphological but distinct immunophenotypic features.
The first patient was a 55-year-old woman. The diagnosis of CLL was made in 1998 when a hematologic work-up was consistent with B-cell CLL, Rai stage 1 [3] , and a low tumor burden by TTM classification [4] . Clinical course was stable, and the patient was observed with no therapy. She was admitted to University Hospital "Merkur" in June Table 1 ). The cytogenetic analysis from the bone marrow sample did not show any chromosomal abnormalities, and the karyotype was: 46, XX [10] .
The second patient was a 59-year-old woman. The previous diagnosis of B-CLL was also made in 1998 with a stable clinical course, and was observed without therapy. She referred to Both patients with previously untreated CLL followed by AL were female of a similar age, with a four-year history of clinically indolent CLL without therapy. Both were referred because of the newly developed leukocytosis. The cytological analysis revealed two separate processes: B-CLL and AML, confirming the diagnosis of bilineal leukemia. Both ALs had the same morphological features consistent with AML M2 by FAB classification. The two ALs had different immunophenotypic features. In the first case, the blasts expressed typical myeloid markers, while in the second case, the blast shared myeloid and lymphoid lineage markers. According to Matutes E. and al., this leukemia could have been considered biphenotypic [5] . Also, the co-expression of CD19 and CD13 antigens supports the diagnosis of the biphenotypic leukemia.
Our results support the other authors' suggestions that the use of full panel of monoclonal antibodies for immunophenotyping is recommended to provide the information about cell heterogeneity, as well as the information of an unexpected second malignancy presence [6, 7] .
Although CLL/AML mixed leukemia is considered very rare, it is possible that the routine use of flow cytometric studies nowadays could affect or modify the epidemiological data. It is possible that CLL, which can initially be asymptomatic, was not diagnosed in more cases presenting with acute leukemia then conventionally expected. Newly developed blast clone could have overgrown previously present CLL clone and relatively reduce lymphocyte mass.
Therefore, reduced lymphocyte population could be considered as non-neoplastic in routine morphological analysis, or in flow cytometry focused on acute leukemia panel. It is possible that the routine use of flow cytometric studies and broad panel of monoclonal antibodies against mature and immature myeloid and lymphoid markers could reveal higher incidence of diagnosis of CLL/AL concomitant leukemia than is believed today.
The etiology of CLL/AL mixed leukemia is not clear [8, 9] . The development of a second acute leukemia in patients with stable CLL suggests the appearance of a new leukemogenic factor. The common characteristics of our patients were the time cluster and the fact that they had both lived at the border of the war area under air strikes. They have been potentially exposed to various toxic agents associated with the military activity in the region. It is known that depleted uranium (DU) has been used in the Balkan War. The potential radiotoxic properties of DU are the subject of controversy. DU has been identified as an oncogeneinducing factor by in vitro studies, as well as in animal models [10, 11] . On the contrary, the epidemiological studies among the Gulf War veterans and UN soldiers did not confirm its cancerogenic potential [12, 13] . Although the hematopoetic system is very sensitive to radiation exposure, the conducted studies have not found an increased incidence of hematologic malignancies among the children or soldiers potentially exposed to DU [12, 14] .
Our patients suffering from a rare leukemia shared a few important epidemiological characteristics, among them the possible exposure to DU. We hope that this fact could add to recent debates on the possible role of depleted uranium (DU) in leukemogenesis. 
